Clifford Chance has advised dsm-firmenich on the deal. KD Pharma Group SA, a contract development and manufacturing organization (CDMO) active in pharmaceutical and nutritional lipids, has...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm Group on the deal. Neuraxpharm Group acquired two portfolios of established products from Sanofi which are marketed globally in more than...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised funds managed by DWS on the deal, while Latham & Watkins has advised Summit Partners on the sale. DWS acquired and integrated Radioonkologienetzwerk...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised the German Medical Technology Association on the deal. The German Medical Technology Association (BVMed) developed the ‘BVMed Compliance Standard’ for the MedTech...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised AXA Investment Managers on the deal. Clifford Chance LLP advised the consortium and Sullivan & Cromwell LLP advised GS Infrastructure. Latham...
You must be a Standard 1 Year member to access this content.
